Table III.
RFS
|
OS
|
|||||
---|---|---|---|---|---|---|
Prognostic factors | HR | 95% CI | P-value | HR | 95% CI | P-value |
ERCC1 level | 0.026 | 0.031 | ||||
<7.32 | 1 | 1 | ||||
≥7.32 | 2.16 | 1.09–4.25 | 2.21 | 1.07–4.55 | ||
Staging | 0.002 | 0.010 | ||||
I, II and III | 1 | 1 | ||||
IV | 3.12 | 1.52–6.42 | 2.81 | 1.29–6.15 | ||
Carcinoembryonic antigen (ng/ml) | 0.012 | 0.050 | ||||
≤5 | 1 | 1 | ||||
>5 | 2.49 | 1.23–5.09 | 2.16 | 0.99–4.68 |
ERCC1, excision repair cross-complementation group 1; RFS, relapse-free survival; OS, overall survival; HR, hazard ratio; CI, confidence interval.